Fulvia Bianchi-Chieco

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study.

Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study.

Journal: Frontiers in immunology

Published: March 31, 2026

Eosinophilic myocarditis: diagnostic pitfalls and therapeutic challenges. A Case Series.

Eosinophilic myocarditis: diagnostic pitfalls and therapeutic challenges. A Case Series.

Journal: Frontiers in cardiovascular medicine

Published: February 26, 2026

Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience.

Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience.

Journal: Annals of medicine

Published: November 03, 2025

Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus.

Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus.

Journal: The journal of allergy and clinical immunology. In practice

Published: May 17, 2023

Biologics and anti-Sars Cov2 vaccination in severe asthma riding the big wave: Unity is strength!

Biologics and anti-Sars Cov2 vaccination in severe asthma riding the big wave: Unity is strength!

Journal: Pulmonology

Published: May 22, 2022

Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.

Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.

Journal: Clinical and molecular allergy : CMA

Published: February 24, 2022

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient.

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient.

Journal: Journal of clinical medicine

Published: December 15, 2021

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control.

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control.

Journal: Vaccines

Published: July 11, 2021

Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy.

Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy.

Journal: The journal of allergy and clinical immunology. In practice

Published: October 11, 2020

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.

Journal: Respiratory medicine

Published: September 07, 2020

COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.

COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.

Journal: Allergy

Published: June 01, 2020

Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era.

Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era.

Journal: Clinical and molecular allergy : CMA

Published: May 27, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026